T.Man Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
T.Man Pharmaceutical has a total shareholder equity of THB1.8B and total debt of THB133.7M, which brings its debt-to-equity ratio to 7.6%. Its total assets and total liabilities are THB2.5B and THB743.6M respectively. T.Man Pharmaceutical's EBIT is THB505.6M making its interest coverage ratio 34.9. It has cash and short-term investments of THB144.1M.
Key information
7.6%
Debt to equity ratio
฿133.66m
Debt
| Interest coverage ratio | 34.9x |
| Cash | ฿144.15m |
| Equity | ฿1.76b |
| Total liabilities | ฿743.59m |
| Total assets | ฿2.50b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TMAN-F's short term assets (THB1.3B) exceed its short term liabilities (THB641.7M).
Long Term Liabilities: TMAN-F's short term assets (THB1.3B) exceed its long term liabilities (THB101.9M).
Debt to Equity History and Analysis
Debt Level: TMAN-F has more cash than its total debt.
Reducing Debt: Insufficient data to determine if TMAN-F's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: TMAN-F's debt is well covered by operating cash flow (311.3%).
Interest Coverage: TMAN-F's interest payments on its debt are well covered by EBIT (34.9x coverage).